학술논문
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18–55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial
Document Type
Article
Author
Ansarifar, A.; Ahi, M.; Sheidaei, A.; Gohari, K.; Rahimi, Z.; Gholami, F.; Bakhshande, H.; Dodaran, M.S.; Farahani, R.H.; Basiri, P.; Moradi, M.; Jahangiri, A.; Naderi, K.; Taghva, Z.; Nia, M.K.; Rahjerdi, A.K.; Ghasemi, S.; Khatami, P.; Honari, M.; Khodaverdloo, S.; Shooshtari, M.; Azin, H.M.; Moradi, S.; Shafaghi, B.; Allahyari, H.; Monazah, A.; Poor, A.K.; Foroughizadeh, M.
Source
In: Vaccine: X . (Vaccine: X, December 2023, 15)
Subject
Language
English
ISSN
25901362